EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Open Access · CC BY 4.0

Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA

Signe Bergliot Nielsen, Nina Munk Lyhne, Maria Andersen, Christina Caroline Plaschke, Anita Birgitte Gothelf, Jørgen Johansen, Christian Maare, Mohammad Farhadi, Christian Godballe, Hanne Primdahl, Anne Ivalu Sander Holm, Jan Alsner und 2 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2024.115211 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Signe Bergliot Nielsen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Aarhus University Hospital, Denmark; Department of Experimental Clinical Oncology, Aarhus…. Hauptthemen laut MEDLINE: Neoplasms, Unknown Primary, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diagnostic and therapeutic management of patients with head and neck squamous cell carcinoma of unknown primary (HNSCCUP) remains a challenge. The aim of the present phase IV study was to assess adherence to the current Danish guidelines and evaluate the treatment outcome in HNSCCUP patients. MATERIALS AND METHODS: Prospectively collected data in the DAHANCA database from patients treated between 2014 and 2020 was evaluated. The median follow-up was 6.7 years. Treatment included definitive neck dissection (dND), primary (chemo-)radiotherapy ((C-)RT), neck dissection (ND) followed by postoperative (C-)RT (ND + (C-)PORT). Outcome were reported as five-year estimates of loco-regional failure (LRF), ultimate LRF (ULRF), disease specific mortality (DSM), overall survival (OS), and toxicity scores ≥ 3. RESULTS: A total of 288 patients were treated, of which 254 (88 %) received treatment with curative intent and were eligible for adherence assessment. These were allocated to dND (n = 60), (C-)RT (n = 81) and ND + (C-)PORT (n = 113). The HPV/p16 status was known in 94 % of patients with 109 (43 %) positive cases. The 5-year LRF, DSM, and OS for patients treated with curative intent was 22 %, 15 % and 73 %, and in patients with p16 positive disease 16 %, 5 %, and 85 %. The overall guideline adherence was 76 % (192/254). In the adherent group the LRF, ULRF, DSM, and OS were 22 %, 11 %, 16 %, and 73 %, respectively. CONCLUSION: The study revealed good treatment outcome measures in HNSCCUP patients subject to the Danish guidelines, comparable to other head and neck cancer patients. The observed guideline-deviations did not affect outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Unknown PrimaryHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckHumansMaleFemaleMiddle AgedAgedDenmarkAdultGuideline AdherenceNeck DissectionProspective StudiesAged, 80 and overPractice Guidelines as TopicTreatment OutcomeChemoradiotherapy

Stichwörter der Autor:innen

ChemoradiotherapyGuideline AdherenceHead and Neck NeoplasmsNeck DissectionPapillomavirus InfectionsPositron Emission Tomography Computed TomographySquamous Cell Carcinoma of Head and NeckSurgical Diagnostic TechniquesTreatment OutcomeUnknown Primary Neoplasms

Autor:innen und Institutionen

  • Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Aarhus University Hospital, Denmark; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: signnils@oncology.a…
  • Department of Oto-rhino-laryngology, Head and Neck Surgery, Aalborg University Hospital, Denmark. Electronic address: n.lyhne@rn.dk.
  • Department of Oncology, Aalborg University Hospital, Denmark. Electronic address: maria.andersen@rn.dk.
  • Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet, Denmark. Electronic address: christina.caroline.plaschke.02@regionh.dk.
  • Department of Oncology, Rigshospitalet, Denmark. Electronic address: Anita.Birgitte.Gothelf@regionh.dk.
  • Department of Oncology, Odense University Hospital, Denmark. Electronic address: jorgen.johansen@rsyd.dk.

Zitieren

APA

Nielsen, S. B., Lyhne, N. M., Andersen, M., Plaschke, C. C., Gothelf, A. B., Johansen, J., Maare, C., Farhadi, M., Godballe, C., Primdahl, H., Holm, A. I. S., Alsner, J., Kjærgaard, T., & Overgaard, J. (2025). Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115211

Vancouver

Nielsen SB, Lyhne NM, Andersen M, Plaschke CC, Gothelf AB, Johansen J, et al. Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2024.115211

BibTeX
@article{Nielsen2025,
  author = {Nielsen, Signe Bergliot and Lyhne, Nina Munk and Andersen, Maria and Plaschke, Christina Caroline and Gothelf, Anita Birgitte and Johansen, Jørgen and Maare, Christian and Farhadi, Mohammad and Godballe, Christian and Primdahl, Hanne and Holm, Anne Ivalu Sander and Alsner, Jan and Kjærgaard, Thomas and Overgaard, Jens},
  title = {Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2024.115211}
}
Kostenlos starten →